Royal College of Obstetricians and Gynaecologists, 2026
Abstract
RCOG response (July 2026) to the NICE draft early-use guidance on Endotest and EndoSure. Underlines that it is draft guidance for consultation, not final approval. Notes Endotest's high reported accuracy comes from carefully selected groups of women with long-standing pelvic pain already at high risk of endometriosis, largely in specialist centres, with most evidence from teams linked to the test's developer in France; robust independent validation in other countries, age and ethnic groups and routine pathways including primary care is limited and urgently needed. Considers EndoSure experimental: near-perfect performance claims arise mainly from small developer-led studies, and both the biological mechanism and real-world performance are unvalidated. Supports linking early use to structured evidence generation.
Topics
Royal College of Obstetricians and Gynaecologists et al. 2026, Royal College of Obstetricians and Gynaecologists 2026
Related articles
fertility-awareness/effectiveness/typical-and-perfect-use clinical-guidelines/guideline-appraisal/evidence-base-and-strength-of-recommendationpostpartum/return-of-fertility/postpartum-charting
Open Access
The State of the Science of Natural Family Planning: A Report from NFP Scientists' Meeting Held in Orlando, FL, September 4, 2024
Manhart MD et al., 2025 · Linacre Q
A one-day meeting was held as a pre-conference to the Catholic Medical Association Annual Educational event in 2024. A panel of eighteen physicians, scientists, and researchers involved in NFP work was convened to review the available evidence in four topical areas: (i) evidence for effectiveness of NFP methods to postpone and achieve pregnancy, (ii) evidence for effectiveness in the postpartum and perimenopause transition periods, (iii) evaluate the current state of technology in NFP (specifically app and quantitative hormone monitoring), and (iv) evidence examining the impact of NFP on marital relations. In each topical area, the panel worked to reach a consensus opinion on the currently available evidence and identified priorities for further research. Results from these discussions and a set of priorities for further work are presented here. An expert panel was convened to review the current evidence supporting use of NFP in various settings, utilization of new technology, and the impact of NFP on marital dynamics. Results from these discussions and a set of priorities for further work are presented here.
gynecology/clinical-practice/practice-patterns endometriosis/diagnosis/diagnostic-delayuterine-and-pelvic-conditions/ovarian-and-adnexal-conditions/ovarian-cysts
Time to Diagnose Endometriosis: Current Status, Challenges and Regional Characteristics-A Systematic Literature Review
De Corte P, 2025 · BJOG : an international journal of obstetrics and gynaecology
Endometriosis diagnosis reportedly faces delays of up to 10 years. Despite growing awareness and improved guidelines, information on the current status is limited. To systematically assess the published evidence on the status of time to diagnosis in individuals with endometriosis, with respect to the definition of time to diagnosis, geographical location and patient characteristics. MEDLINE (via PubMed) and Embase were searched for publications reporting time to diagnosing endometriosis since 2018. No restrictions to population or comparators were applied. All publications were screened by two independent reviewers. Search results were limited to primary publications of randomised controlled trials, non-randomised trials and observational studies. Case reports, secondary publications and grey literature were excluded. No restrictions were made regarding language, provided that an English title and abstract were available. Publications were assessed with respect to time to diagnosis, diagnostic methods, study type, study country and potential bias. The 17 publications eligible for inclusion in this literature review were all observational studies. The publications reported diagnosis times between 0.3 and 12 years, with variations depending on the definition of time to diagnosis (overall, primary, or clinical), geographical location and characteristics of the included study population. Evidence was of poor to good quality overall. Diagnostic delay is still present, primarily driven by physicians, and this review underscores the need for standardised definitions, increased awareness and targeted diagnostic interventions.
diagnostics/endometrial-assessment/luteal-phase-biopsy contraception/long-acting-methods/intrauterine-devicesassisted-reproduction/outcomes/outcomes-by-diagnosis
Hormonal Contraception and Endometrial Thickness in IVF/ICSI Cycles: A Multicentre Historical Cohort Study
Michaelsen MP et al., 2025 · BJOG: An International Journal of Obstetrics and Gynaecology
To study the association between previous use of levonorgestrel intrauterine system (LNG-IUS) and endometrial thickness (EMT) in women undergoing in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles. Multicentre historical cohort study. Eight Danish public and private fertility clinics. 12786 women aged 18-46 years contributing with an EMT measurement from 22 464 different IVF/ICSI treatment cycles between 2000 and 2021. Exposure was previous use of LNG-IUS, combined oral contraceptive pills (OCPs), progestogen-only pills (POPs), no/other contraception or combined, cumulated use of contraception when more contraceptives had been used during the inclusion period. LNG-IUS use was categorised into 0-3 years, >3-6 years, >6-9 years and >9 years. Mixed effect logistic regression adjusted for age, BMI, smoking, educational level, total FSH dose and fertility clinic was used. EMT (< 7 mm vs >= 7 mm). Statistically significantly higher odds of EMT >= 7 mm were found for OCPs [OR 3.53 (95% CI 1.29-9.65)], POPs [OR 6.43 (95% CI 1.45-28.63)] and no/other contraception [OR 6.67 (95% CI 2.37-18.74)] relative to LNG-IUS in IVF/ICSI cycles. All duration categories of ever use of LNG-IUS were associated with significantly lower odds of EMT >= 7 mm compared to no/other contraception. Previous use of LNG-IUS was associated with decreased endometrial growth in women undergoing IVF/ICSI.
endometriosis/surgical-treatment/recurrence-after-surgery uterine-and-pelvic-conditions/ovarian-and-adnexal-conditions/ovarian-cystsgynecology/clinical-practice/practice-patterns
The Long-term Rate of Repeat Surgery After Optimal Excision Surgery of Endometriosis at a Single Tertiary Referral Center
Yeung P et al., 2025 · Acta Scientific Women's Health
The primary purpose of this prospective cohort study was to determine if treating endometriosis with optimal excision surgery leads to lower rates of repeat surgery as compared to historical rates of repeat surgery by ablation. A secondary outcome was to examine whether the use of hormonal suppression differed before surgery, depending on the stage of endometriosis found at surgery. Optimal excision was defined as completely excising all areas of abnormal peritoneum, wherever found in the pelvis, having looked systematically with near contact laparoscopy. All surgeries were performed by a single surgeon specializing in optimal excision at a tertiary referral center. The rate of repeat surgery after optimal excision surgery for endometriosis was remarkably low (2.5%, 15/620) as compared to historical rates of repeat surgery by ablation. Additionally, the lack of significant evidence between hormonal suppression use and progression of stage of endometriosis provides implicit evidence that hormonal suppression does not prevent progression of the disease. Further controlled studies are needed to verify these findings.